Abalos Therapeutics is supported by a syndicate of prestigious life science investors including Boehringer Ingelheim Venture Funds, High-Tech Gründerfonds, NRW.Bank and Gründerfonds Ruhr.


We have established successful relationships with renowned academic and service partners and are always looking out for new collaborations to further advance our innovative immuno-virotherapy approach.

Consent Management Platform by Real Cookie Banner